Fernwood Investment Management’s Acceleron Pharma XLRN Stock Holding History

Fernwood Investment Management’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-9,400	Closed	-$1.62M	–	219
2021 Q3	$1.62M	Buy	9,400 +1,000	+12%	+$131K	0.56%	52
2021 Q2	$1.05M	Hold	8,400	–	–	0.35%	84
2021 Q1	$1.14M	Sell	8,400 -800	-9%	-$103K	0.42%	74
2020 Q4	$1.18M	Sell	9,200 -100	-1%	-$11.7K	0.46%	62
2020 Q3	$1.05M	Sell	9,300 -4,600	-33%	-$458K	0.49%	60
2020 Q2	$1.32M	Buy	13,900 +10,900	+363%	+$1.05M	0.65%	49
2020 Q1	$270K	Buy	+3,000	New	+$233K	0.17%	118

Fernwood Investment Management's XLRN Position: Q4 2021 in Review

Fernwood Investment Management sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 9,400 shares — an estimated $1.62M sold.

Fernwood Investment Management first reported a position in XLRN in Q1 2020 and held it in 7 quarters. The position peaked at $1.62M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Fernwood Investment Management reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Fernwood Investment Management sold 9,400 Acceleron Pharma shares in Q4 2021, an estimated $1.62M.
Fernwood Investment Management first reported a position in Acceleron Pharma in Q1 2020 and held it in 7 quarters.
Fernwood Investment Management's Acceleron Pharma position peaked at $1.62M in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Fernwood Investment Management's 13F filing for Q4 2021, filed 9 Feb 2022.